Nuzenio

Regenxbio

Regenxbio news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 10:48:50 GMTRGNX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Sat, 08 Aug 2026 06:05:03 GMTREGENXBIO (NASDAQ:RGNX) Rating Increased to Hold at Wall Street Zen - MarketBeat
Sat, 08 Aug 2026 01:48:16 GMTMorgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $18 - news.futunn.com
Sat, 08 Aug 2026 00:56:44 GMTREGENXBIO (RGNX) Stock Drops Despite Profit Surprise And Longer Cash Runway - simplywall.st
Fri, 07 Aug 2026 19:06:22 GMTA Quick Look at Today's Ratings for Regenxbio(RGNX.US), With a Forecast Between $12 to $45 - Moomoo
Fri, 07 Aug 2026 17:37:18 GMTRegenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says - marketscreener.com

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Regenxbio.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.